Skip to main content
Premium Trial:

Request an Annual Quote

Celera Genomics Pockets $32M Following Sale of Discovery Partners Stake

NEW YORK, May 12 (GenomeWeb News) - Celera Genomics has pocketed $32 million after selling its one-third stake in Discovery Partners International, the company said today.


The Applera unit sold 7,222,000 shares of Discovery Partners common stock in a public offering at a price of $5 per share. Celera Genomics took possession of these shares in November 2001after it acquired Axys Pharmaceuticals, which owned them since 2000, according to Celera spokesman Rob Bennett.


Bennett said the companies agreed to the move because DPI wanted to have additional shares on the market for institutional investors, and Celera could find a better use for its money.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.